Haleon PLC 6-K Filing
Ticker: HLN · Form: 6-K · Filed: Apr 7, 2026 · CIK: 0001900304
Sentiment: neutral
Filing Stats: 732 words · 3 min read · ~2 pages · Grade level 7.3 · Accepted 2026-04-07 08:27:20
Filing Documents
- a3364z.htm (6-K) — 56KB
- a3364z000.jpg (GRAPHIC) — 3KB
- 0001654954-26-003276.txt ( ) — 61KB
From the Filing
IN OWN SHARES a3364z UNITED STATES   SECURITIES AND EXCHANGE COMMISSION   Washington, D.C. 20549     FORM 6-K   REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934   For the month of April 2026   Commission File Number: 001-41411   Haleon plc (Translation of registrant’s name into English)   Building 5, First Floor, The Heights, Weybridge, Surrey, KT13 0NY (Address of principal executive offices)     Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:     Form 20-F ☒   Form 40-F ☐       EXHIBIT INDEX   Exhibit Number   Description   99.1 07 April 2026 - “Transactions in Own Shares”       Haleon plc:   Aggregated information - transactions in own shares   7 April 2026:   Haleon plc (the "Company" or "Haleon") today announces   the purchase of 5,266,782 ordinary shares of £0.01 each in the Company (the "Shares") for cancellation   under its share buyback programme announced on 12 March 2026.     London Stock Exchange CBOE (UK)/BXE CBOE (UK)/CXE Aquis Date of purchase: 30 March 2026 Number of Shares purchased: 400,900 16,735 20,439 - Highest price paid per Share (p): 374.7000 374.7000 374.7000 - Lowest price paid per Share (p): 368.1000 370.6000 370.6000 - Volume weighted average price paid per Share (p): 369.7187 372.9532 372.5379 - Date of purchase: 31 March 2026 Number of Shares purchased: 559,566 309,537 430,897 - Highest price paid per Share (p): 379.1000 379.1000 379.1000 - Lowest price paid per Share (p): 373.6000 373.6000 373.6000 - Volume weighted average price paid per Share (p): 375.8642 376.0574 375.9833 - Date of purchase: 1 April 2026 Number of Shares purchased: 794,952 486,092 718,956 - Highest price paid per Share (p): 376.3000 376.3000 376.3000 - Lowest price paid per Share (p): 370.4000 370.4000 370.4000 - Volume weighted average price paid per Share (p): 372.9529 373.1379 373.1820 - Date of purchase: 2 April 2026 Number of Shares purchased: 613,820 384,073 530,815 - Highest price paid per Share (p): 374.1000 373.9000 374.0000 - Lowest price paid per Share (p): 369.5000 369.5000 369.5000 - Volume weighted average price paid per Share (p): 371.6621 371.5836 371.6343 -   Following the settlement of the above, the Company's registered share capital   is 8,927,564,553 ordinary shares of £0.01 each, of which 12,493,360 are held as treasury shares.   Therefore, the number of ordinary shares with voting rights is 8,915,071,193 and   this figure may be used by shareholders to determine if they are required to notify their interest, or a change to their interest, in Haleon under the FCA's Disclosure Guidance and Transparency Rules.   In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 as it applies in the UK (the Market Abuse Regulation), a full breakdown of the individual trades is available at the link below:   http://www.rns-pdf.londonstockexchange.com/rns/3357Z_1-2026-4-2.pdf   This announcement does not constitute, or form part of, an offer or any solicitation of an offer for securities in any jurisdiction.   This announcement and individual trade breakdown will also be available on the Company's website at:   www.haleon.com/investors .   Enquiries     Investors Media Jo Russell   +44 7787 392441 Zoë   Bird +44 7736 746167 Rakesh Patel      +44 7552 484646 Victoria Durman +44 7894 505730 Email:   investor-relations@haleon.com Email:   corporate.media@haleon.com   About Haleon Haleon (LSE/NYSE: HLN) is a consumer company that is solely focused on better everyday health. Our people, our brands, our research, our investment and our innovation are aimed at improving the everyday health of consumers. Our product portfolio spans six major categories - Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health, Digestive Health and Therapeutic Skin Health and Other. Our superior brands - such as  Advil ,  Centrum ,  Otrivin ,  Panadol ,  parodontax ,  Polident ,  Sensodyne ,  Theraflu  and  Voltaren  - are trusted by more than one billion consumers and are recommended by health professionals around the world.   For more information, please visit   www.haleon.com .    SIGNATURE     &